October 7, 2021

Recently, TRIMEDX’s Scott Trevino, senior vice president for product management and solutions, and Tim McGeath, special counsel, visited Washington, D.C., as part of an Alliance for Quality Medical Device Servicing delegation.

The group met with several individuals on Capitol Hill raising awareness around Independent Service Organizations, who we are, what we do, and what value we bring and role we play in providing health systems a choice as they work to provide safe and high-quality medical equipment management which ultimately impacts patient care and safety.

This is the first trip the Alliance has made to D.C. since the start of the pandemic. Typically, on these trips, representatives from ISOs will meet with legislators from both the House and Senate as well as with individuals from organizations such as the Food and Drug Administration & the Federal Trade Commission.

In the effort to inform and generate additional awareness, the group discusses topics such as Right to Repair and the importance of access to those materials to service medical devices. In this visit, they also reinforced FDA findings in its 2018 shared FDARA Report that concluded that third-party ISOs “provide high-quality, safe and effective servicing of medical devices”.1 This was also an opportunity to have conversations around the Medical Device User Fee Amendments (MDUFA) Reauthorization Act to emphasize the value ISOs bring to healthcare organizations, not to mention the very important role Independent Service Organizations play in delivering cybersecurity protection of medical equipment through the solutions they provide to health systems.

Scott Trevino is the senior vice president of product management and solutions at TRIMEDX. In his role, Trevino partners with marketing, business development and business unit presidents to develop and drive the product strategy and execution for TRIMEDX’s technology and integrated analytics portfolio. He and his team of product managers manage the portfolio’s alignment to business strategy and outcomes, strategic product roadmap, market definition, product innovation, development prioritization, pricing and profitability.

¹FDA FDARA Report

Related links: